GOLGA6L9 Activators
GOLGA6L9 activators constitute a niche within the broader realm of chemical agents that interact with specific proteins encoded by the human genome. The designation GOLGA6L9 refers to a particular gene product-a protein that plays a role within the complex machinery of the eukaryotic cell. The term activators signifies compounds that can increase the activity or expression of the GOLGA6L9 protein. These activators, through their interaction, can modulate the function of the protein, often by affecting its conformation, its stability, or its interactions with other cellular components. Their mode of action is typically characterized by binding to the target protein in a manner that promotes its biological activity, which may involve facilitating the protein's proper folding, enhancing its ability to interact with other proteins or nucleic acids, or stabilizing its active form.
The biochemical pathways and cellular processes that GOLGA6L9 activators influence are diverse, reflecting the multifaceted roles that the GOLGA6L9 protein may play within the cell. The GOLGA6L9 gene is a member of the golgin family of proteins, which are predominantly associated with the Golgi apparatus-a critical organelle involved in processing and sorting proteins and lipids in the cell. Activators of GOLGA6L9 could potentially impact various cellular functions, such as intracellular trafficking, membrane dynamics, and organelle organization. The exact mechanisms by which these activators exert their effect are the subject of molecular investigations, often involving a combination of structural biology, biochemistry, and cell biology techniques.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin increases intracellular cAMP levels, which in turn can activate PKA. PKA phosphorylation can influence Golgi apparatus dynamics and maintenance, potentially enhancing the function of GOLGA6L9 in Golgi organization and trafficking. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) which is known to phosphorylate proteins involved in vesicular trafficking. This activation may indirectly enhance GOLGA6L9's role in vesicle-mediated processes within the Golgi apparatus. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG has inhibitory effects on a variety of kinases and can alter signaling pathways. By modulating these pathways, EGCG may indirectly enhance the functional activity of GOLGA6L9 in the Golgi apparatus by influencing vesicle formation and trafficking. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts Golgi structure by inhibiting ADP-ribosylation factor (ARF), which may lead to compensatory mechanisms that indirectly enhance GOLGA6L9 activity to maintain Golgi apparatus integrity. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole disrupts microtubules, leading to Golgi fragmentation. This can trigger cellular mechanisms that attempt to restore Golgi integrity, potentially enhancing the function of GOLGA6L9 in Golgi reassembly and maintenance. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium influences several signaling pathways, including the Wnt/GSK-3 pathway. By inhibiting GSK-3, Lithium can affect the structure of the Golgi apparatus, potentially enhancing the functional activity of GOLGA6L9 in Golgi-related processes. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin is a sodium ionophore that disrupts ionic gradients across the Golgi membrane, affecting vesicle trafficking. This disruption could indirectly enhance GOLGA6L9 activity by modulating the Golgi apparatus's function in protein sorting and trafficking. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases PP1 and PP2A. By altering the phosphorylation status of Golgi-associated proteins, it may indirectly enhance the functional activity of GOLGA6L9 in the Golgi apparatus. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine raises the pH in intracellular organelles including the Golgi apparatus, which can affect protein sorting and processing. This alteration could lead to enhanced GOLGA6L9 function in maintaining Golgi apparatus dynamics and protein trafficking. | ||||||